Creative Minds Care was founded with a simple vision: a world without Alzheimer's disease and other neurodegenerative disorders.

​

I lost my grandmother to Alzheimer's disease at a young age. Years later, while serving as a Celebrity Champion for the Alzheimer's Association, my story was published in Chicken Soup for the Soul: Living with Alzheimer's and Other Dementias. As I learned more about Alzheimer's research and the challenges of funding promising ideas early enough to make a difference, I became convinced that strategic philanthropy could help accelerate progress. I realized that my career in the arts had given me something powerful: the ability to connect people, inspire action, and bring communities together around a shared purpose. Creative Minds Care was born from that belief and from a desire to turn purpose into action.

​

From the beginning, our goal has been simple: identify and support research that has the greatest potential to prevent, slow, and ultimately eliminate neurodegenerative disease. We seek out research that combines scientific rigor with the potential to meaningfully advance brain health. We believe every philanthropic dollar should be invested thoughtfully and strategically where it has the greatest opportunity to accelerate progress.

​

Over time, our understanding of brain health has grown alongside the science. We now recognize that protecting the brain begins long before disease appears. Genetics matter, but so do the environments we create, the air we breathe, the food we eat, the sleep we get, our social connections, and the scientific discoveries we choose to advance. Creative Minds Care supports innovative research, education, and collaborative initiatives that advance lifelong brain health while continuing to prioritize breakthrough research in Alzheimer's disease, Parkinson's disease, Lewy Body Dementia, and related neurodegenerative disorders.

​

Since founding Creative Minds Care, we have partnered with leading institutions and organizations including UCSF and the Weill Institute for Neurosciences, the University of Chicago, NewYork-Presbyterian, Cure Alzheimer's Fund, the Michael J. Fox Foundation, and many others. Together, these collaborations have supported research spanning artificial intelligence for early detection, biomarkers, neurogenesis, the gut microbiome, women's brain health, and the role of estrogen in Alzheimer's disease, sleep and the brain's waste clearance systems, and other innovative approaches to understanding, preventing, and treating neurodegenerative disease. We have also established scholarships and fellowships to help develop the next generation of neuroscience leaders and built partnerships with organizations that share our vision of a world without neurodegenerative disease.

 

We recognize that no single discovery will solve neurodegenerative disease. Lasting progress will come from many breakthroughs working together. That is why we continually evaluate emerging science and invest where the evidence points us next. Our commitment remains constant: to seek out bold ideas, support outstanding researchers, and invest in research with the greatest potential to transform the future of brain health.

 

​

​